 |
인쇄하기
취소
|
Hanall wins local patent for combination drug
Hanall Biopharma (formerly Hanall Pharmaceutical) announced on April 26 that it has acquired a patent for 'HL-012', a combination drug containing simvastatin and aspirin.
The patent is characterized by its innovated drug delivery system, through which simvastatin and aspirin are released over 24 hours.
The major advantage and uniqueness of this patent product is to maintain blood glucose ...
The patent is characterized by its innovated drug delivery system, through which simvastatin and aspirin are released over 24 hours.
The major advantage and uniqueness of this patent product is to maintain blood glucose ...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.